ArticleExperimental and therapeutic medicine2022

miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways.

Li Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.